483
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd. – FDA 483, Feb 28, 2019
Record Details
An FDA inspection of Otsuka Pharmaceutical Co., Ltd., a drug substance manufacturer in Omagari, Japan, identified two significant issues. The firm failed to thoroughly investigate and document unexpected discrepancies, including inadequate root cause analysis and delayed corrective actions. Additionally, the inspection found insufficient control over warehouse temperatures for raw materials and finished API, with validation failing to establish proper air conditioning settings.
View Company Profile
ID · 39f40888-2a2c-4828-8d2c-ad2de5a90622
Other documents for Otsuka Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.